02.10.2017
- Japan’s Asahi Kasei and China’s Bluestar, a ChemChina subsidiary, have agreed to study the economics of building production facilities for producing a modified polyphenylene ether...
10.07.2017
- In 1975, Asahi Kasei began the first commercial chlor-alkali production using the membrane electrolysis process. This industrial process for the electrolysis of sodium chloride...
10.03.2016
- Japan’s Asahi Kasei has set up a German subsidiary based in Düsseldorf as a springboard for further expansion in Europe. Asahi Kasei Europe will start trading on Apr. 1 with a...
29.05.2015
- Asahi Kasei and Mitsubishi Chemical plan to merge their two 500,000 t/y crackers at the Mizushiman site operated by Nishi Nippon Ethylene in Japan's Okayama prefecture. To operate...
30.07.2014
- For Europe's chlor-alkali industry, reduction of its rising production costs, especially energy costs, is now a pressing priority. This is not only because of the sector's low...
12.03.2012
- Japan's Asahi Kasei will buy U.S. medical equipment maker Zoll Medical for $2.21 billion as it looks to build a globally competitive healthcare business and reduce its reliance on...
04.05.2011
- Europe's largest biotech Actelion was dealt a blow when a jury in a Californian court said Japanese drugmaker Asahi Kasei should be awarded up to $547 million in a licensing...
02.05.2011
- Swiss biotech group Actelion is now facing a tougher battle at its annual general meeting this week after a jury decided Asahi Kasei Pharma Corporation should be awarded up to $547...
